Latest News
ANZ Shares Gain Ahead of Key Quarterly Update and Mortgage Rate Hike
ANZ shares rose 1.7% to A$37.63 as investors await Thursday's first-quarter trading update. The bank will increase variable home loan rates by 0.25 percentage points from February 13.
WiseTech Global Rebounds 4.3% as Tech Sector Stabilizes, Eyes on Upcoming Earnings
WiseTech Global shares surged 4.3% to A$49.66, recovering from recent software sector declines. Investors now await the company's half-year results scheduled for February 25.
Nebius AI Stock Undervalued Amid Projected Revenue Surge to $9B
Nebius Group's AI computing stock appears discounted with forward P/S under 7, as revenue is projected to leap from $551M to up to $9B in 2026. Meanwhile, Asian dividend stocks and blockchain leaders attract investor attention.
AT&T Shares Dip Amid Broad Market Gains, Focus Shifts to Key Economic Data
AT&T stock declined 0.7% to $27.13 on Friday, underperforming a broader market rally that pushed the Dow Jones Industrial Average above 50,000. Investors are now awaiting delayed U.S. employment and inflation reports.
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus
Gilead Sciences reached a 52-week high after the FDA approved a label update for its Yescarta therapy, expanding use to a rare brain lymphoma. The stock's rally comes ahead of the company's quarterly earnings report.
Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data
Abbott Laboratories stock rose 1.6% Friday following a director's $1.09 million share purchase and new clinical data for its heart rhythm devices presented at a medical symposium.
Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show
Walt Disney Co's stock will be monitored Monday after U.S. regulators launched an investigation into ABC's 'The View' regarding election airtime rules. Shares closed Friday at $108.70, up 3.6%.
Texas Instruments Slashes Capex, Eyes Silicon Labs Deal Amid Insider Sales
Texas Instruments shares fell 1.13% as the company plans to cut 2026 capital spending to $2-3 billion and fund its Silicon Labs acquisition with cash and debt. Key executives sold shares after exercising options.
Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats
Novo Nordisk B shares surged 5.29% after Hims & Hers halted its $49 compounded version of Wegovy, with the FDA pledging action against unauthorized copycats. The stock remains down roughly 20% over five sessions amid pricing uncertainty.
Linde Shares Face Pressure After JPMorgan Downgrade, Focus Turns to Pricing Outlook
Linde stock fell 2.53% to $448.07 Friday after JPMorgan cut its rating to Neutral, citing valuation and flat sequential pricing. Investors await U.S. jobs data and company conferences this week.